Rossard A, Barrier J, Audran M, Dubigeon P, Grolleau J Y, Hervouët D
Nouv Presse Med. 1979 Feb 17;8(8):593-4, 599-600.
We describe two patients who had a typical levamisole-induced agranulocytosis and a severe infection; the view of other cases found in the literature shows a fundamental fact: the complication can occur after a variable time of prescription (from thirteen days to eleven months), continuous or intermittent. The accidents are imprevisible, and circonspection must be used, not for its antihelminthic properties, but for its prolonged use for immunological purposes, even if some authors have not observed any cases of agranulocytosis in large series. Naturally, the purpose is quite different in the case of a severe rheumatoid arthritis or inesthetic warts, and our two observations are very demonstrative. Mechanism of agranulocytosis has not been totaly clarified: we have observed biological stigmates of immunological process against levamisole (responsible of agranulocytosis?), but essentially medullary lesions (successive regenerative aspects and necrosis) as has been described with pyramidon, and this could explain why the other blood cells are affected in an apparently isolated agranulocytosis.
我们描述了两名患有典型的左旋咪唑诱发的粒细胞缺乏症并伴有严重感染的患者;从文献中发现的其他病例来看,有一个基本事实:这种并发症可在用药后的不同时间出现(从13天到11个月),用药方式可为持续或间断。这些不良反应是不可预测的,必须谨慎使用,不是因其抗蠕虫特性,而是因其用于免疫目的的长期使用,即便有些作者在大量病例中未观察到粒细胞缺乏症的任何病例。当然,在严重类风湿性关节炎或尖锐湿疣的情况下目的截然不同,而我们的这两例观察极具说明性。粒细胞缺乏症的机制尚未完全阐明:我们观察到了针对左旋咪唑的免疫过程的生物学特征(是粒细胞缺乏症的病因?),但主要是骨髓病变(相继出现的再生现象和坏死),正如在氨基比林中所描述的那样,这可以解释为什么在明显孤立的粒细胞缺乏症中其他血细胞也会受到影响。